Anabolic-androgenic steroids: Effects on social behavior and baseline heart rate.

1990 ◽  
Vol 9 (6) ◽  
pp. 774-791 ◽  
Author(s):  
W. Jack Rejeski ◽  
Edward Gregg ◽  
Jay R. Kaplan ◽  
Stephen B. Manuck
Author(s):  
Maria Christou ◽  
Panagiota Christou ◽  
Georgios Markozannes ◽  
Agathocles Tsatsoulis ◽  
George Mastorakos ◽  
...  

1996 ◽  
Vol 42 (7) ◽  
pp. 1001-1020 ◽  
Author(s):  
W Schänzer

Abstract Anabolic androgenic steroids (AAS) are misused to a high extent in sports by athletes to improve their physical performance. Sports federations consider the use of these drugs in sports as doping. The misuse of AAS is controlled by detection of the parent AAS (when excreted into urine) and (or) their metabolites in urine of athletes. I present a review of the metabolism of AAS. Testosterone is the principal androgenic steroid and its metabolism is compared with that of AAS. The review is divided into two parts: the general metabolism of AAS, which is separated into phase I and phase II metabolism and includes a systematic discussion of metabolic changes in the steroid molecule according to the regions (A-D rings), and the specific metabolism of AAS, which presents the metabolism of 26 AAS in humans.


2017 ◽  
Vol 24 (9) ◽  
pp. 1210-1220 ◽  
Author(s):  
Marc Harris ◽  
Michael Dunn ◽  
Tina Alwyn

An estimated 293,000 people living in the United Kingdom have used anabolic-androgenic steroids. However, there is currently no intervention to reduce usage available in practice or academic circulation throughout the United Kingdom. This study aimed to test a novel hypothesis that increased levels of intrasexual competition may play an important influential role in the use of anabolic-androgenic steroids. Significantly higher levels of intrasexual competition were evident in users compared to non-users but only in the novice group (0–2 years of experience). The research provides evidence for intrasexual competition potentially influencing anabolic-androgenic steroid use but only during the initial stages of usage.


2016 ◽  
Vol 46 (10) ◽  
pp. 2121-2131 ◽  
Author(s):  
V. K. Jandackova ◽  
A. Britton ◽  
M. Malik ◽  
A. Steptoe

BackgroundPeople with depression tend to have lower heart rate variability (HRV), but the temporal sequence is poorly understood. In a sample of the general population, we prospectively examined whether HRV measures predict subsequent depressive symptoms or whether depressive symptoms predict subsequent levels of HRV.MethodData from the fifth (1997–1999) and ninth (2007–2009) phases of the UK Whitehall II longitudinal population-based cohort study were analysed with an average follow-up of 10.5 years. The sample size for the prospective analysis depended on the analysis and ranged from 2334 (644 women) to 2276 (602 women). HRV measures during 5 min of supine rest were obtained. Depressive symptoms were evaluated by four cognitive symptoms of depression from the General Health Questionnaire.ResultsAt follow-up assessment, depressive symptoms were inversely associated with HRV measures independently of antidepressant medication use in men but not in women. Prospectively, lower baseline heart rate and higher HRV measures were associated with a lower likelihood of incident depressive symptoms at follow-up in men without depressive symptoms at baseline. Similar but statistically insignificant associations were found in women. Adjustments for known confounders including sociodemographic and lifestyle factors, cardiometabolic conditions or medication did not change the predictive effect of HRV on incident depressive symptoms at follow-up. Depressive symptoms at baseline were not associated with heart rate or HRV at follow-up in either sex.ConclusionsThese findings are consistent with an aetiological role of the autonomic nervous system in depression onset.


Sign in / Sign up

Export Citation Format

Share Document